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sion of surgical techniques, and provides the surgeon
with a controlled environment in which to perform pre-
cision anastomoses.2 Despite these benefits, the seque-
lae of hyperkalemic arrest may be detrimental.
Hyperkalemic arrest contributes to the development of
myocardial edema, which has been implicated in left
ventricular dysfunction, arrhythmogenesis, and a loss of
compliance.3-5 Furthermore, myocardial edema con-
tributes to the “no-reflow” phenomenon and diminishes
drug efficacy.6,7
It is well established that normal human and rabbit
cardiomyocytes undergo cardioplegia-induced cell
swelling in the absence of ischemia as a consequence of
the composition of the cardioplegic solution.8-10 The
cell volume of normal cardiomyocytes appears to be
governed by a Donnan equilibrium under hypothermic
conditions. As a result, exposure to cold isosmotic St
Thomas’ Hospital solution causes cell swelling because
M yocardial protection by means of cardioplegicarrest was first proposed by Melrose and col-
leagues1 almost half a century ago. Cardioplegic arrest
offers enhanced tissue protection, has led to the exten-
Objectives: We hypothesized that the cell volume of ventricular myocytes
isolated from hearts in volume-overload congestive failure would respond
differently to hypothermic cardioplegia than would sham-operated cohorts.
Methods: Adult rabbits underwent either valvotomy and aortic regurgita-
tion–induced heart failure or sham surgery. Congestive failure was con-
firmed clinically and by means of echocardiography. Cell volumes of isolat-
ed myocytes were measured by digital video microscopy. After equilibration
in 37°C physiologic solution, cells were suprafused with 9°C standard or
low-Cl– St Thomas’ Hospital solution followed by reperfusion in 37°C phys-
iologic solution.
Results: Exposure to cold St Thomas’ Hospital solution for 20 minutes
caused sham myocytes to swell by 8% (n = 9); cell volumes fully recovered
on normothermic reperfusion. In contrast, congestive failure myocytes (n =
9) maintained their cell volume in cold St Thomas’ Hospital solution and
during reperfusion. Lowering the [K+][Cl–] product of St Thomas’ Hospital
solution by partially replacing Cl– with an impermeant anion prevented cel-
lular edema in the sham group (n = 8) but caused a 4% swelling in failure
myocytes (n = 10) on reperfusion. Osmotically shrinking the failure cells
(n = 9) converted their behavior to that of sham cells. 
Conclusions: In the absence of ischemia, congestive failure myocytes are less
sensitive to cardioplegia-induced edema than sham cells. Low-Cl– cardio-
plegia, which prevents edema and protects the normal heart, induced
swelling and may be detrimental in myopathic hearts. Differences in volume
regulation in failure and sham myocytes may be due to activation of volume-
sensitive channels that are turned off by osmotic shrinkage. (J Thorac
Cardiovasc Surg 2000;119:826-33)
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RABBIT VENTRICULAR MYOCYTE VOLUME CHANGES AS A DIRECT RESULT OF CRYSTALLOID 
CARDIOPLEGIA IN CONGESTIVE HEART FAILURE INDUCED BY AORTIC REGURGITATION
its [K+][Cl–] product is higher than that of plasma.
Moreover, methods directed at diminishing cellular
edema by altering the [K+][Cl–] product of St Thomas’
Hospital solution correlate with an improved function-
al recovery after global ischemia in the intact heart.11
Although these studies are intriguing, they were con-
ducted on normal myocytes. Consequently, the impli-
cations for diseased hearts is uncertain.
Patients with left ventricular dysfunction have an
over 10-fold greater risk of perioperative mortality than
subjects with normal ventricular function during coro-
nary revascularization procedures.12 The failing heart
exhibits an altered postischemic recovery of function13
and coronary vascular dysfunction13,14 when compared
with the normal heart. In myocytes isolated from hearts
with ventricular dysfunction, a decreased contractile
function, decreased response to catecholamines, and
altered calcium metabolism were noted during cardio-
plegic arrest and reperfusion.15
One possibility is that negative outcomes in dysfunc-
tional hearts are caused in part by cellular edema.
Recent studies suggest that myocyte cell volume regu-
lation is altered in congestive heart failure (CHF).16,17
In this setting ion channels with activities modulated
by cell volume become persistently activated.
Myocytes isolated from failure animals demonstrated
several properties analogous to normal cells subjected
to osmotic stress. We therefore hypothesized that car-
dioplegic solution tonicity, its effect on cell volume, is
influenced by myocardial disease. We predicted that
cellular edema caused by hypothermic cardioplegic
solution would be different in myocytes isolated from a
dilated CHF model18 than in sham-operated cohorts. 
Materials and methods
Heart failure model. Heart failure was induced as previ-
ously described.18 Adult New Zealand White rabbits of either
sex (2.5-3.0 kg, 3 months old) were randomized to one of two
surgical intervention groups: (1) the CHF group underwent
dilated cardiomyopathy induced by aortic regurgitation, and
(2) the sham group underwent a sham operation. All animals
received humane care in accordance with the Guide for the
Care and Use of Laboratory Animals (revised 1996) prepared
by the Institute of Laboratory Animal Resources and pub-
lished by the National Academy Press. Rabbits were sedated
(acepromazine maleate [INN: acepromazine], 2.5 mg/kg;
xylazine, 5 mg/kg) and anesthetized (ketamine, 20 mg/kg).
Atropine (0.25 mg/kg) was given to avoid the bradycardic
effect of xylazine.
In the CHF group aortic regurgitation was induced in a
closed chest model. Aortic valvotomy was performed through
the right internal carotid artery by using a 4F dilator/sheath
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(C.R. Bard, Inc, Billerica, Mass). Arterial pressures were
continuously monitored through the inner lumen of the dila-
tor. The dilator was advanced inside the sheath until resis-
tance was encountered and a ventricular waveform was
obtained. The dilator was then withdrawn back into the intro-
ducer, and the blood pressure was monitored for 5 minutes.
Additional passes across the valve cusps were performed
until the arterial pulse pressure widened by at least 10 mm
Hg. The right internal carotid artery was then ligated without
event. In the sham group the right internal carotid artery was
isolated and ligated. Ventricular function was assessed at 8
weeks with 2-dimensional echocardiography (Hewlett-
Packard Sonos 2500, 7-MHz pediatric probe). By using the
parasternal short-axis view, 2-dimensional images of the left
ventricle were obtained at the mid papillary muscle level. At
end-diastole and end-systole, left ventricular internal diame-
ters (LVIDs) and left ventricular wall thicknesses were deter-
mined in both the anteroposterior and lateral directions.
Fractional shortening of the left ventricle was calculated as
follows: (LVIDdiastole – LVIDsystole)/LVIDdiastole.
Pulsed Doppler and color Doppler echocardiography were
used to verify aortic regurgitation. At the time of death, all
rabbits in the CHF group were noted to have pulmonary con-
gestion and pleural and pericardial effusions. Grossly, hearts
were markedly enlarged and hypertrophied.
Myocyte isolation. Isolated single ventricular cardiomyo-
cytes were obtained from the two experimental groups by
identical methods. Animals were sedated (acepromazine
maleate, 25 mg/kg; xylazine, 5 mg/kg), heparinized (1000
IU), and anesthetized (ketamine, 35 mg/kg). Protocols for
ventricular myocyte isolation with collagenase and pronase
were previously described.8,10,19 Yields of rod-shaped, Ca2+-
tolerant sham and CHF myocytes were similar.
Volume measurements. An aliquot of myocytes was placed
in a glass-bottomed chamber and suprafused with 37°C physi-
ologic Tyrode solution at a rate of 4.5 to 5.0 mL/min. Cells
were allowed to equilibrate for at least 20 minutes before the
application of experimental interventions. Cells selected for
study remained adherent to the chamber bottom (coverslip)
and were quiescent throughout the experiment.
Methods used for determining cell volume previously were
described in detail.8-10,19 With each cell used as its own con-
trol, relative cell volume was calculated as follows:
volumetest/volumecontrol = (areatest × widthtest)/
(area
control × widthcontrol).
Relative cell volume is independent of the assumed cross-
sectional shape of the myocyte. These methods provide esti-
mates of relative cell volume that are reproducible to less than
1%.8,10,19 Except as noted, all cell volume data are presented
as the percentage change in relative cell volume by using
each cell as its own control.
Experimental protocol. Protocols consisted of sequential
equilibration, experimental, and reperfusion periods, each 20
minutes in duration. Cells were allowed to equilibrate and
were reperfused in normothermic (37°C) physiologic Tyrode
solution. Experimental periods subjected the two groups of
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cells to either hypothermic (9°C) cardioplegia with standard
St Thomas’ Hospital solution or low-Cl– St Thomas’ Hospital
solution, which has demonstrated beneficial effects on cell
volume in the normal myocyte.8-10 To determine whether the
CHF group was behaving in a similar fashion to normal cells
subjected to osmotic stress, CHF cells were artificially con-
tracted in a hypertonic (1.5 T) normothermic Tyrode solution
followed by suprafusion in a hypertonic (1.5 T) hypothermic
(9°C) St Thomas’ Hospital solution and reperfusion in a
hypertonic (1.5 T) normothermic Tyrode solution. Images for
the repeated measurement of volume were acquired from
each myocyte at 18 and 20 minutes of equilibration in physi-
ologic Tyrode solution and then every 5 minutes during the
experimental and reperfusion periods. Complete sets of vol-
ume measurements were obtained on 28 CHF myocytes from
4 animals with aortic regurgitation and 17 control myocytes
from 4 sham-operated animals.
Solutions. Modified Tyrode solution (osmolarity = 296 ± 2
mOsm; [K+][Cl–] product = 700 mmol2/L2) contained the fol-
lowing: NaCl, 130 mmol/L; KCl, 5 mmol/L; MgSO4, 2
mmol/L; glucose, 10 mmol/L; and N-2-hydroxyethylpiper-
azine-N-2-ethanesulfonic acid, 5 mmol/L; titrated to pH 7.4
with NaOH. Hyperosmotic Tyrode solution (osmolarity =
436 ± 1 mOsm; [K+][Cl–] product = 700 mmol2/L2) was
made by adding 140 mmol/L mannitol to isosmotic Tyrode
solution. St Thomas’ Hospital solution (osmolarity = 292 ± 1
mOsm; [K+][Cl–] product = 2566.4 mmol2/L2) contained the
following: NaCl, 110 mmol/L; NaHCO3, 10 mmol/L; MgCl2,
16 mmol/L; KCl, 16 mmol/L; and CaCl2, 1.2 mmol/L. To
decrease the [K+][Cl–] product of St Thomas’ Hospital solu-
tion (Cl– = 160.4 mmol/L), Cl– was partially substituted by
equimolar concentrations of methanesulfonate, an imperme-
ant anion. This low-Cl– variant of St Thomas’ Hospital solu-
tion contained the following: Na-methanesulfonate, 110
mmol/L; NaHCO3, 10 mmol/L; MgCl2, 16 mmol/L; KCl,
9.35 mmol/L; K-methanesulfonate, 6.65 mmol/L; and CaCl2,
1.2 mmol/L (osmolarity = 293 ± 2 mOsm; [K+][Cl–] product
= 700 mmol2/L2; [Cl–] = 43.75 mmol/L). Hyperosmotic St
Thomas’ Hospital solution (osmolarity = 440 ± 3 mOsm;
[K+][Cl–] product = 2566.4 mmol2/L2) was made by adding
140 mmol/L mannitol to St Thomas’ Hospital solution. All
variants of St Thomas’ Hospital solution were bubbled with
95% oxygen and 5% carbon dioxide and adjusted to pH 7.4.
Statistical analysis. Results are expressed as means ± SE,
and n refers to the number of myocytes studied, except in
Table I, where n refers to the number of hearts. All statistical
calculations were performed by using SigmaStat 2.0 (SPSS,
Inc, Chicago, Ill). A 1-way repeated-measures analysis of
variance was used for sequential time-based measurements.
Treatment significance was evaluated by an F ratio test, and
individual treatment means were compared with control val-
ues by means of a Dunnett post test. The post test controls the
overall error rate for all comparisons in the data set, and crit-
ical values were calculated at a P value of less than .01 and a
P value of less than .05. A P value of less than .05 was accept-
ed as statistically significant.
Results
Echocardiographic data. Table I summarizes
echocardiographic data demonstrating that aortic
regurgitation caused a substantial left ventricular dila-
tion in the population studied at 8 weeks. Left ven-
tricular internal diameter and left ventricular internal
area were significantly increased (P < .01) in both
systole and diastole in CHF hearts compared with
sham hearts. Fractional shortening in CHF hearts
decreased by more than 40% (P < .01). No significant
change in left ventricular wall thickness was detected,
however (P = .51). These data are consistent with
those of Magid and colleagues,18 who found that an
initial phase of hypertrophy in response to aortic
regurgitation is supplanted by volume overload and
dilation after 2 weeks and that dilatory changes reach
a plateau after 6 weeks.
Myocyte volume. The initial volumes of sham and
CHF myocytes after equilibration in 37°C physiologic
Tyrode solution were estimated, assuming that
myocytes are cylindrical. Aortic regurgitation induced
about a 12% increase in cell volume from 57.9 ± 4.1 (n
= 17) to 64.6 ± 7.9 pL (n = 19; P = .47, unpaired t test).
Because of the naturally occurring wide variation in
myocyte size, these estimates may not precisely reflect
population parameters.
Table I. Echocardiographic parameters in the intact rabbit heart 8 weeks after surgery
Parameter Sham CHF CHF-sham ratio P value
LVIDdiastole (cm) 0.88 ± 0.06 1.49 ± 0.09 1.69 <.01
LVID
systole (cm) 0.52 ± 0.03 1.13 ± 0.08 2.17 <.01
LVWTdiastole (cm) 0.22 ± 0.03 0.26 ± 0.05 1.18 .51
LVIAdiastole (cm2) 0.62 ± 0.04 1.67 ± 0.14 2.69 <.01
LVIA
systole (cm2) 0.25 ± 0.03 0.92 ± 0.08 3.68 <.01
FS 0.46 ± 0.02 0.27 ± 0.03 0.59 <.01
Mean ± SEM for sham (n = 4) and CHF (n = 4) animals measured at end-systole and end-diastole by 2-dimensional echocardiography at 8 weeks. LVID, Left ven-
tricular internal diameter; LVWT, left ventricular wall thickness; LVIA, left ventricular internal cross-sectional area; FS, fractional shortening calculated as follows:
(LVIDdiastole – LVIDsystole)/LVIDdiastole.
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The effect of St Thomas’ Hospital solution on rel-
ative cell volume. The relative cell volume of sham
myocytes was stable during 20 minutes in 37°C physi-
ologic Tyrode solution. However, sham myocytes
swelled during suprafusion of hypothermic (9°C) St
Thomas’ Hospital solution in the absence of ischemia
(Fig 1, A; n = 9). After 5 minutes, the relative cell vol-
ume of sham myocytes increased by 6.8% ± 1.2% (P <
.01) and further increased to 7.8% ± 1.2% (P < .01)
after 20 minutes. On reperfusion in normothermic
physiologic Tyrode solution, these cells returned to
control volumes within 5 minutes, and cell volume
remained constant throughout the remainder of the 20-
minute reperfusion period. In contrast, hypothermic St
Thomas’ Hospital solution did not significantly alter
the volume of myocytes isolated from rabbits in CHF
(Fig 1, B; n = 9) during either the 20-minute experi-
mental period or the 20-minute normothermic physio-
logic reperfusion period (P = .95). The swelling of
sham myocytes in cold cardioplegic solution is similar
to that previously observed in atrial and ventricular
myocytes isolated from normal rabbit hearts8-10 and
Fig 1. Effect of hypothermic cardioplegia and reperfusion in normothermic physiologic solution on relative cell
volume in ventricular myocytes isolated from sham (A, n = 9) and volume-overload CHF (B, n = 9) hearts. After
a 20-minute equilibration period in 37°C physiologic Tyrode solution (TY), myocytes were exposed to 9°C St
Thomas’ Hospital solution (STS) for 20 minutes and then were reperfused with 37°C physiologic solution for 20
minutes. Each cell was used as its own control to calculate relative cell volume. A, Cold St Thomas’ Hospital
solution induced significant cellular edema in sham cells that fully reversed on reperfusion with normothermic
physiologic solution. B, In contrast, the volume of CHF cells remained constant in cold St Thomas’ Hospital solu-
tion and during normothermic reperfusion. **P < .01 compared with initial volume in physiologic solution.
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human atrial myocytes.9 This swelling was attributed to
myocyte cell volume regulation according to a Donnan
equilibrium in the cold. However, failure of CHF
myocytes to swell suggests that volume regulation is
more complicated in CHF cells.
The effect of low-Cl– St Thomas’ Hospital solution
on relative cell volume. We previously demonstrated
that the detrimental edematous effects of St Thomas’
Hospital solution can be ameliorated by reducing the
Cl– concentration and thereby the [K+][Cl–] product of
St Thomas’ Hospital solution (2566.4 mmol2/L2) to a
more physiologic range (700 mmol2/L2) consistent
with the internal milieu of the cell.8-10 Fig 2, A,
demonstrates that volume regulation in the sham
group of myocytes behaved as expected for cells gov-
erned by Donnan equilibrium. Sham myocytes (n = 8)
maintained a constant volume during suprafusion in
low-Cl– St Thomas’ Hospital solution (compared with
Fig 1, A) and remained at control volumes during nor-
mothermic physiologic reperfusion (P = .48).
Myocytes isolated from the CHF group (Fig 2, B; n =
10) also maintained constant volume during suprafu-
sion of low-Cl– St Thomas’ Hospital solution. In con-
trast to the sham group, CHF cells became edematous
Fig 2. Effect of hypothermic low-Cl– St Thomas’ Hospital solution on sham (A, n = 8) and CHF (B, n = 10)
myocytes. After a 20-minute equilibration period in 37°C physiologic Tyrode solution (TY), myocytes were
exposed to 9°C low-Cl– St Thomas’ Hospital solution (LCSTS) for 20 minutes and then were reperfused with
37°C physiologic solution for 20 minutes. A, Low-Cl– St Thomas’ Hospital solution prevented cellular edema
during hypothermic cardioplegia in sham myocytes (compared with Fig 1, A). B, In contrast, exposure of CHF
myocytes to low-Cl– St Thomas’ Hospital solution caused a significant increase in cell volume during reperfu-
sion. *P < .05 compared with initial volume in physiologic solution.
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during reperfusion in normothermic physiologic solu-
tion. The swelling was statistically significant at 10
and 15 minutes (4.1% ± 1.3% [P < .05] and 4.3% ±
1.0% [P < .05], respectively). Thereafter, these cells
remained edematous, but the swelling did not reach
statistical significance.
CHF cells under hypothermic hypertonic condi-
tions behave similarly to sham cells in the cold. We
previously demonstrated under isotonic conditions that
myocytes isolated from hearts in CHF display chronic
activation of ICl,swell,16 an outwardly rectifying Cl– cur-
rent, and ICir,swell,17 an inwardly rectifying poorly selec-
tive cation current. These channels are only active in
the normal myocyte when cells are subjected to osmot-
ic swelling. By artificially shrinking CHF myocytes in
hypertonic solutions, both volume-sensitive currents
are turned off.16,17 If these volume-regulatory channels
are playing an active role in the maintenance of cellu-
lar volume in failure myocytes, then one would expect
that their inactivation should result in cellular swelling
in cold cardioplegic solution similar to that noted in the
normal heart.
Fig 3 shows the result of an experiment testing this
idea. Previous studies16,17 showed that normal and CHF
myocytes shrink by 20% to 25% in the hyperosmotic
Tyrode solution used here. After an equilibration peri-
od in hyperosmotic Tyrode solution, CHF myocytes (n
= 9) were noted to swell in equally hyperosmotic
hypothermic St Thomas’ Hospital solution. Maximal
swelling was noted at 15 minutes of suprafusion (4.5%
± 1.4%, P < .01). These cells remained edematous
throughout the remainder of the equilibration period
and then returned to baseline volumes during normo-
thermic hyperosmotic Tyrode solution reperfusion.
Discussion
Cellular edema during cardioplegia results from an
inability of myocytes to appropriately maintain cell
volume. Our understanding of cell volume regulation
in the adult heart under hypothermic conditions is
incomplete. During hypothermia, the volume of normal
atrial and ventricular myocytes responds to the
[K+][Cl–] product of the bathing media as expected for
a Donnan equilibrium.8-10 Under Donnan equilibrium,
transmembrane ion fluxes keep the product of the K+
and Cl– concentrations on both sides of the plasmalem-
ma equal. When normal myocytes are exposed to St
Thomas’ Hospital solution at 9°C, a solution that is
isosmotic but has a more than 3-fold greater [K+][Cl–]
product than plasma or crystalloid physiologic solu-
tions, an influx of K+ and Cl– is expected. Water pas-
sively follows this ion influx, and cellular edema
occurs.8-10 Because ion channel and transporter func-
tion is temperature dependent, the extent of cell
Fig 3. Effect of osmotic shrinkage on the response of CHF cells to cardioplegia. The osmolarity of both physio-
logic Tyrode solution and St Thomas’ Hospital solution were increased to 1.5 times isosmotic by addition of man-
nitol. After a 20-minute equilibration period in 37°C hyperosmotic Tyrode solution (1.5T), myocytes were
exposed to 9°C hyperosmotic St Thomas’ Hospital solution (1.5-STS) for 20 minutes and then were reperfused
with 37°C hyperosmotic Tyrode solution for 20 minutes. CHF myocytes (n = 9) significantly swelled in cold
hyperosmotic St Thomas’ Hospital solution and fully recovered during reperfusion with normothermic hyperos-
motic Tyrode solution. Osmotic shrinkage, which closes volume-sensitive ion channels, converted the behavior
of CHF cells to that of sham cells (compared with Fig 1). Cell volumes were calculated relative to that in hyper-
osmotic Tyrode solution. *P < .05; **P < .01 compared with initial volume in hyperosmotic Tyrode solution.
swelling during cardioplegia also can vary with tem-
perature.10 Even small changes in myocyte volume may
have important implications for cardiac function in the
intact heart when perfusion is restricted, as in cardio-
plegia. Shifts of water and ions from the small extra-
cellular space to the much larger intracellular compart-
ment will alter transmembrane ionic gradients, and
cellular edema can limit reperfusion.
The present studies documented that ventricular
myocytes from CHF hearts behave differently from
normal myocytes in hypothermic St Thomas’ Hospital
solution. In contrast to previous results in normal cells,
CHF cells maintained a constant volume during 20
minutes of 9°C hyperkalemic cardioplegia and nor-
mothermic reperfusion (Fig 1, B). Moreover, the vol-
ume of CHF cells was unaffected by low-Cl– St
Thomas’ Hospital solution, but surprisingly, cellular
edema developed on normothermic physiologic reper-
fusion (Fig 2, B). These data imply that volume regula-
tion in CHF cells during hypothermia and normother-
mic reperfusion cannot be fully explained by Donnan
equilibrium. It is likely that the alterations in the intra-
cellular ionic milieu that arise during cold cardioplegia
in CHF myocytes are different from those in normal
myocytes. Such differences may set the stage for the
development of cellular edema on normothermic reper-
fusion of CHF cells.
The behavior of CHF cells was not due to operative
manipulations because the results in sham-operated
myocytes were consistent with previous studies of nor-
mal myocytes.8-10 As expected, sham myocytes rapidly
swelled on exposure to hypothermic St Thomas’
Hospital solution, and cell volume completely recov-
ered on normothermic physiologic reperfusion (Fig 1,
A). Exposing sham myocytes to a low-Cl– variant of St
Thomas’ Hospital solution with a physiologic [K+][Cl–]
product (700 mmol2/L2) completely prevented cardio-
plegia-induced cellular edema and confirmed that these
cells follow Donnan equilibrium under hypothermic
conditions (Fig 2, B).
Several pathologic changes occurring in the setting of
heart failure relate to ion transport and thereby may
directly or indirectly influence the development of cel-
lular edema. Metabolically, there is a decrease in the
nucleotide pool14 and altered calcium handling.15 The
activity of the Na+-Ca2+ exchanger20 and Na+-K+
pump21 are diminished. In addition, we recently report-
ed that cation17 and anion16 channels that are activated
by osmotic swelling in normal cells were persistently
turned on in CHF cells. These channels pass sufficient
current to alter ionic gradients and can directly influ-
ence cell volume. Volume-sensitive channels are inhib-
ited by osmotic shrinkage,16,17 and in the present study
CHF cells in hyperosmotic cold St Thomas’ Hospital
solution (Fig 3) behaved much like sham cells under
isosmotic conditions (Fig 1, A). Taken together, these
data suggest that volume-sensitive channels may be
important in minimizing the development of cellular
edema in CHF cells during cardioplegia, although the
contribution of other transport systems in limiting
edema in CHF cells cannot be ruled out at the present
time. Volume-sensitive channels also may be important
for cell volume regulation during ischemia-induced
edema.
Functional implications. Both intact myocardium
and isolated cells from CHF hearts have a blunted
response to inotropic agents and a decreased contractile
function under basal conditions.13,15 Furthermore, cells
isolated from failure hearts demonstrate a decreased
contractile function after hyperkalemic arrest.14,22
These findings emphasize the need for a cardioplegic
solution designed to optimize myocardial protection in
CHF and diminish myocardial stunning. Jayawant and
colleagues11 demonstrated the beneficial effects of
low-Cl– St Thomas’ Hospital solution in ameliorating
myocardial stunning and maintained atrioventricular
conduction times in intact normal hearts, an improve-
ment attributed to the prevention of cellular edema. It
remains unclear whether low-Cl– St Thomas’ Hospital
solution also is beneficial in hypertrophic or dilated
cardiomyopathy. If avoiding cell edema during cardio-
plegia is critical to the protection offered by low-Cl– St
Thomas’ Hospital solution in the normal heart,11 the
present results suggest that this experimental cardio-
plegic solution would be detrimental in volume-over-
load failure. In a pressure-overload model of hypertro-
phy, Bénitah and colleagues23 described an outwardly
rectifying Cl– channel that was persistently activated. It
is unclear whether this anion channel is distinct from
the one we previously described in volume-overload
failure.16 Nevertheless, their finding raises the possibil-
ity that the cell volume response to cardioplegia in
pressure overload–induced pathologic states also is dis-
tinct from that of normal myocardium.
Limitations of the study. These studies were per-
formed on isolated myocytes, and extrapolation to the
intact heart and the clinical situation requires caution.
Although differences in cell volume regulation were
identified in myocytes, it is unclear how the intact heart
in volume-overload failure will respond to ischemic
arrest in standard and low-Cl– St Thomas’ Hospital solu-
tion. The role of autonomic, endocrine, and geometric
factors that are present in the intact heart but not in iso-
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lated cells is unknown. Furthermore, confounding fac-
tors, such as cardiopulmonary bypass and ischemia, that
are present in a clinical context were not included in the
present study. Nevertheless, this study reinforces the idea
that research performed in the normal heart should not
be uncritically extrapolated to pathophysiologic states.
Conclusion
In the absence of ischemia, ventricular myocytes iso-
lated from rabbits in CHF were more resistant to
hypothermic cardioplegia-induced cellular edema than
sham-operated cohorts. Altered cell volume regulation
and the resistance to cellular edema may be due in part
to the persistent activation of volume-sensitive chan-
nels in CHF cells and their contribution to cell volume
regulation. Although low-Cl– St Thomas’ Hospital
solution offers improved myocardial protection in nor-
mal intact hearts, further work is necessary to evaluate
whether this formulation is beneficial in the setting of
poor ventricular function and CHF. Studies that consid-
er ischemic and pressure-overload cardiomyopathies
also would be useful.
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